Patterns of Relapse and Associated Cost Burden in Schizophrenia Patients Receiving Atypical Antipsychotics

被引：0
|
作者：
Lafeuille, Marie-Helene [1 ]
Gravel, Jonathan [1 ]
Lefebvre, Patrick [1 ]
Fasteneau, John [2 ]
Muser, Erik [2 ]
Doshi, Dilesh [2 ]
Dug, Mei Sheng [3 ]
机构：
[1] Grp Anal Ltee, Montreal, PQ, Canada
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Anal Grp Inc, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
952
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of atypical antipsychotics in the CATIE schizophrenia trial
    Rosenheck, RA
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S32 - S32
  • [22] Relapse Prevention in Patients with Schizophrenia: Antipsychotics under Examination
    Lorenz, Judith
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2024, 92 (11) : 443 - 444
  • [23] Review: maintenance antipsychotics prevent relapse in patients with schizophrenia
    Agid, Ofer
    Remington, Gary
    EVIDENCE-BASED MENTAL HEALTH, 2012, 15 (04) : 92 - 92
  • [24] Hyperglycemia is undiagnosed in many patients receiving atypical antipsychotics
    不详
    CNS SPECTRUMS, 2006, 11 (02) : 84 - 85
  • [25] Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia
    Hamann, J
    Mischo, C
    Langer, B
    Leucht, S
    Kissling, W
    PSYCHIATRIC SERVICES, 2005, 56 (11) : 1448 - 1450
  • [26] Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five - Year Historical Cohort Study
    Ahmadkhaniha, Hamid-Reza
    Bani-Hashem, Shahab
    Ahmadzad-Asl, Masoud
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2014, 8 (01) : 66 - 71
  • [27] A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics
    He, Luyao
    Yu, Yimin
    Zhang, Lei
    He, Shen
    Yu, Wenjuan
    Li, Lujin
    Huang, Jingjing
    Li, Huafang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 71 - 74
  • [28] Switching to aripiprazole from atypical antipsychotics in patients with schizophrenia
    Kim, S. W.
    Lee, J. H.
    Lee, Y. H.
    Chung, K. H.
    Ryu, J. H.
    Yoon, J. S.
    Kim, J. M.
    Yoo, J. A.
    Youn, T.
    Bae, K. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S488 - S489
  • [29] Impact of atypical antipsychotics on the treatment of patients with schizophrenia in Japan
    Tomita, M.
    Watanabe, K.
    Inagaki, A.
    Den, R.
    Nakagawa, A.
    Takeuchi, H.
    Kikuchi, T.
    Tomita, A.
    Tsunoda, K.
    Kitta, M.
    Yagi, G.
    Kashima, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S279 - S279
  • [30] Effectiveness of atypical antipsychotics for substance use in schizophrenia patients
    Swanson, Jeffrey
    Van Dorn, Richard A.
    Swartz, Marvin S.
    SCHIZOPHRENIA RESEARCH, 2007, 94 (1-3) : 114 - 118
12345